Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ <sup>177</sup> Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ <sup>68</sup> Ga]Ga-PSMA PET

Eighteen-minute 360° cadmium zinc telluride (CZT) total-body <sup>177</sup>Lu-labeled SPECT acquisitions on the single 113-keV <sup>177</sup>Lu photopeak (SP-18) have been reported to be suitable for monitoring [<sup>177</sup>Lu]Lu-PSMA therapy. This study evaluated dual-energy 113- and 208-keV acquisitions with a more than 2-fold increase in acquired counts, allowing acquisition time to be reduced to 9 min (DP-9). <b>Methods:</b> In 20 patients with prostate cancer, 360° CZT total-body <sup>177</sup>Lu-labeled SPECT acquisitions performed after the first [<sup>177</sup>Lu]Lu-PSMA therapeutic injection were reconstructed as SP-18, DP-9, and dual-energy 18-min reconstructions (DP-18), all from the same list-mode dataset, and tumor volume and SUV<sub>mean</sub> were compared. A standard pretherapy [<sup>68</sup>Ga]Ga-PSMA PET was also used as an external imaging reference. <b>Results:</b> DP-9 yielded tumor volume and SUV<sub>mean</sub> that were comparable to those of DP-18. Compared with SP-18, DP-9 produced lower tumor volumes (median percentage difference, −15% [interquartile range, −25% to −12%]) with similar SUV<sub>mean</sub>. Compared with PET, both SP-18 and DP-9 showed higher SUV<sub>mean</sub> (+14% [+7% to + 36%] and +19% [−3% to +38%], respectively), likely reflecting the longer injection-to-imaging delay for SPECT, and higher tumor volumes (+68% [+5% to + 122%] and +47% [−15% to +95%], respectively), consistent with the lower spatial resolution of SPECT. Phantom results were similar for SPECT reconstructions, with PET showing better recovery coefficients for SUV and volume. <b>Conclusion:</b> Dual-energy 360° CZT total-body [<sup>177</sup>Lu]Lu-PSMA SPECT/CT enables 9-min acquisitions while providing tumor volume and SUV<sub>mean</sub> measurements comparable to those of the previously validated 18-min single-energy protocol. Tumor volumes are lower than those with SP-18 but are closer to PET-derived values. Differences between SPECT and PET mainly reflect the injection-to-imaging time for SUV<sub>mean</sub> and the spatial resolution for tumor volume.

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine
Published
2026-07-23
DOI
https://doi.org/10.2967/jnumed.126.272647
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ 177 Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ 68 Ga]Ga-PSMA PET

Laëtitia Imbert, Caroline Boursier, Sébastien Heyer, Abdelaali Zouaoui et al.
Journal of Nuclear Medicine
Radiopharmaceutical Chemistry and Applications
article

Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ 177 Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ 68 Ga]Ga-PSMA PET

Laëtitia Imbert, Caroline Boursier, Sébastien Heyer, Abdelaali Zouaoui, Antoine Verger, Marine Claudin, Nathaniel Roth, Raphaël Blum, Pierre Olivier, Pierre-Yves Marie
article en

Abstract

Eighteen-minute 360° cadmium zinc telluride (CZT) total-body <sup>177</sup>Lu-labeled SPECT acquisitions on the single 113-keV <sup>177</sup>Lu photopeak (SP-18) have been reported to be suitable for monitoring [<sup>177</sup>Lu]Lu-PSMA therapy. This study evaluated dual-energy 113- and 208-keV acquisitions with a more than 2-fold increase in acquired counts, allowing acquisition time to be reduced to 9 min (DP-9). <b>Methods:</b> In 20 patients with prostate cancer, 360° CZT total-body <sup>177</sup>Lu-labeled SPECT acquisitions performed after the first [<sup>177</sup>Lu]Lu-PSMA therapeutic injection were reconstructed as SP-18, DP-9, and dual-energy 18-min reconstructions (DP-18), all from the same list-mode dataset, and tumor volume and SUV<sub>mean</sub> were compared. A standard pretherapy [<sup>68</sup>Ga]Ga-PSMA PET was also used as an external imaging reference. <b>Results:</b> DP-9 yielded tumor volume and SUV<sub>mean</sub> that were comparable to those of DP-18. Compared with SP-18, DP-9 produced lower tumor volumes (median percentage difference, −15% [interquartile range, −25% to −12%]) with similar SUV<sub>mean</sub>. Compared with PET, both SP-18 and DP-9 showed higher SUV<sub>mean</sub> (+14% [+7% to + 36%] and +19% [−3% to +38%], respectively), likely reflecting the longer injection-to-imaging delay for SPECT, and higher tumor volumes (+68% [+5% to + 122%] and +47% [−15% to +95%], respectively), consistent with the lower spatial resolution of SPECT. Phantom results were similar for SPECT reconstructions, with PET showing better recovery coefficients for SUV and volume. <b>Conclusion:</b> Dual-energy 360° CZT total-body [<sup>177</sup>Lu]Lu-PSMA SPECT/CT enables 9-min acquisitions while providing tumor volume and SUV<sub>mean</sub> measurements comparable to those of the previously validated 18-min single-energy protocol. Tumor volumes are lower than those with SP-18 but are closer to PET-derived values. Differences between SPECT and PET mainly reflect the injection-to-imaging time for SUV<sub>mean</sub> and the spatial resolution for tumor volume.

Journal of Nuclear Medicine
Inserm (FR), Centre d’Investigation Clinique Innovation Technologique de Nancy (FR), Imagerie Adaptative Diagnostique et Interventionnelle (FR), Université de Lorraine (FR)
Affordable and clean energy
Openalex Percentile: Top 9%
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.